Results 181 to 190 of about 7,632 (199)
Some of the next articles are maybe not open access.

Comparison of Xrn1 and Rat1 5′→3′ exoribonucleases in budding yeast supports the unique role of Xrn1 in co-translational mRNA decay

2023
The yeast Saccharomyces cerevisiae and most eukaryotes carry two 5’→3’ exoribonuclease paralogues that are very similar. In yeast, they are called Xrn1, which shuttles between the nucleus and cytoplasm and executes major cytoplasmic mRNA decay, and Rat1, which carries a strong nuclear localization sequence (NLS) and localizes in the nucleus. Xrn1 is 40%
Jose Perez-Ortin   +8 more
openaire   +1 more source

5′-Exoribonuclease 1: Xrn1

2001
Publisher Summary The detection, purification, and partial characterization of 5′-exoribonuclease 1 (Xrn1) from Saccharomyces cerevisiae as a 160-kDa RNase was reported in 1980 and 1985. The enzyme is a processive exonuclease hydrolyzing RNA from the 5′ end with the production of 5′-mononucleofides.
openaire   +2 more sources

XRN1: A Major 5′ to 3′ Exoribonuclease in Eukaryotic Cells

2012
The degradation of RNA is a critical aspect of gene regulation. Correspondingly, ribonucleases exist within the cell to degrade RNA in specific cellular contexts. An important and conserved ribonuclease is called XRN1. This enzyme, an exoribonuclease, degrades RNA in a processive 5' to 3' direction.
Sarah, Geisler, Jeff, Coller
openaire   +2 more sources

Immunohistochemical localization of exoribonucleases (DIS3L2 and XRN1) in intranuclear inclusion body disease

Neuroscience Letters, 2018
mRNA turnover controls gene expression under various conditions in aging and neurodegenerative diseases. Polyglutamine (polyQ) diseases and intranuclear inclusion body disease (INIBD) are neurodegenerative diseases characterized by the formation of nuclear inclusions.
Fumiaki, Mori   +8 more
openaire   +2 more sources

Detection and quantification of RNA decay intermediates using XRN1-resistant reporter transcripts

Nature Protocols, 2019
RNA degradation ensures appropriate levels of mRNA transcripts within cells and eliminates aberrant RNAs. Detailed studies of RNA degradation dynamics have been heretofore infeasible because of the inherent instability of degradation intermediates due to the high processivity of the enzymes involved. To visualize decay intermediates and to characterize
Franka Voigt   +6 more
openaire   +2 more sources

Xrn1 controls Parp9/14 activation.

Activation of the enzymes Parp9 and Parp14 is a common transcriptional feature of pathways important for IBD, identified by gene or casual variant of interest, including NOD2, TRIM22, and XIAP.  Aberrant Parp9/14 pathway signaling is found in NOD2 mutant cells and in patient tissues of humans with IBD (Crohn's Disease).
openaire   +1 more source

Home - About - Disclaimer - Privacy